Pharma in Brief
AUGUST 9, 2021
On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. Generic drugs and biosimilars are not eligible for this application pathway. Biologic Drugs. Proposed Amendments.
NPR Health - Shots
OCTOBER 18, 2022
For context, we speak to the authors of The Truth Pill: The Myth of Drug Regulation in India. The World Health Organization has issued an alert about the deaths in the West African nation of Gambia. Image credit: Milan Berckmans/AFP via Getty Images)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
MAY 19, 2022
The US Food and Drug Administration (FDA) posted the company’s recall announcement , which includes a complete list of products affected by the recall. . So why is metal contamination such a common reason for launching voluntary recalls? The Mars recall impacted 13 product stock keeping units (SKUs) ranging from 3.5-ounce
The Pharma Data
FEBRUARY 19, 2022
Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. This alert covers FDA-regulated products purchased from Family Dollar stores in those six states from Jan. Today, the U.S. Families rely on stores like Family Dollar for products such as food and medicine.
XTalks
SEPTEMBER 12, 2022
New regulations are often reflective of the supply chain, food safety and consumer trends. Here are some of the top food industry regulations food and beverage companies should watch out for in 2022. Changes to the US Food and Drug Administration’s Definition of “Healthy”. Regulating Heavy Metals in Baby Food.
FDA Law Blog
NOVEMBER 9, 2023
Food and Drug Administration (FDA) issued a proposed rule that would amend its prior notice regulations to add new information requirements and deadlines. food supply is safe by shifting the focus of federal regulators from responding to contamination to preventing it. By Sophia R.
STAT News
JANUARY 19, 2023
In a stunning rebuke, the Food and Drug Administration accused a drugmaker of a “cascade of failures” for a litany of quality-control problems at a manufacturing plant, the latest instance in which the regulator has castigated an Indian pharmaceutical company for such lapses.
Expert insights. Personalized for you.
98 
Let's personalize your content